Hill J M, Wiggins C A, Kwon B S, Gentry G A, Gangarosa L P
Methods Find Exp Clin Pharmacol. 1984 Jan;6(1):17-20.
The antiviral agent thymine arabinoside (9-beta-D-arabinofuranosyl thymine, Ara-T) was applied topically and by anodal (+) iontophoresis in a NaCl solution to Herpes simplex virus type 1 (HSV-1), and Herpes simplex virus type 2 (HSV-2) skin infections in hairless mice. The chemotherapeutic efficacy of Ara-T was evaluated employing the parameters of mean lesion score, number of mice with signs of neurological involvement (paralysis), mortality and mean survival time. Anodal (+) iontophoresis of 0.4% Ara-T in a 0.1 M NaCl solution significantly suppressed HSV-1 skin infection, but the infection was not altered by topical application of 3% Ara-T. HSV-2 infection was refractory to both topical and iontophoretic application of Ara-T. This is the first report of the in vivo efficacy of Ara-T for HSV-1 skin infections.
抗病毒药物阿糖胸腺嘧啶核苷(9-β-D-阿拉伯呋喃糖基胸腺嘧啶,Ara-T)以局部用药和在氯化钠溶液中通过阳极(+)离子导入法应用于无毛小鼠的1型单纯疱疹病毒(HSV-1)和2型单纯疱疹病毒(HSV-2)皮肤感染。采用平均损伤评分、出现神经受累体征(麻痹)的小鼠数量、死亡率和平均存活时间等参数评估Ara-T的化疗效果。在0.1 M氯化钠溶液中0.4%的Ara-T进行阳极(+)离子导入可显著抑制HSV-1皮肤感染,但局部应用3%的Ara-T对感染无影响。HSV-2感染对Ara-T的局部用药和离子导入均无效。这是关于Ara-T对HSV-1皮肤感染体内疗效的首次报道。